Carlyle Group Inc. - Q3 2022 holdings

$3.15 Billion is the total value of Carlyle Group Inc.'s 12 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 44.4% .

 Value Shares↓ Weighting
ZI SellZoomInfo Technologies Inc$1,583,972,000
+14.4%
38,021,415
-8.8%
50.30%
+110.6%
 Quidelortho Corp$890,654,000
-26.4%
12,460,1830.0%28.28%
+35.5%
MKSI NewMKS Instrs Inc$280,405,0003,393,093
+100.0%
8.90%
ONEM  1Life Healthcare Inc$233,457,000
+118.8%
13,612,6810.0%7.41%
+302.9%
VTRU  Vitru Ltd$130,988,000
+20.0%
6,246,4710.0%4.16%
+120.9%
LSI NewLife Storage Inc$9,525,00086,000
+100.0%
0.30%
CUBE NewCubeSmart$8,833,000220,500
+100.0%
0.28%
SMHI  Seacor Marine Hldgs Inc$6,725,000
-2.4%
1,196,6490.0%0.21%
+79.8%
EM  Smart Sh Global Ltdads$3,367,000
-36.9%
4,810,2090.0%0.11%
+16.3%
SPNT  SiriusPoint Ltd$641,000
-8.6%
129,4080.0%0.02%
+66.7%
 Meta Data Limitedsponsored ads$324,000
-30.3%
314,4000.0%0.01%
+25.0%
ATC ExitAtotech Ltd$0-153,672,703
-100.0%
-51.28%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
eFFECTOR Therapeutics, Inc.August 18, 20234,829,8917.8%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
QuidelOrtho CorpJune 06, 202212,460,18318.6%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
ARS2024-04-18
DEF 14A2024-04-18
DEFA14A2024-04-18
8-K2024-04-03
PRE 14A2024-04-03
42024-04-02
SC 13G2024-03-29
8-K2024-03-27
42024-03-05
SC 13D/A2024-03-05

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Export Carlyle Group Inc.'s holdings